Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers

Area of Science:

• Gastroenterology
• Oncology
• Molecular Pathology

Background:

• Post-colonoscopy colorectal cancers (PCCRCs) are a concern, potentially arising from missed lesions or aggressive tumor biology.
• Understanding the distinct characteristics of PCCRCs compared to cancers detected during colonoscopy is crucial for improving screening and diagnosis.

Purpose of the Study:

• To compare the clinical, pathological, and molecular features of PCCRCs (diagnosed 6-60 months post-colonoscopy) with colorectal cancers (CRCs) detected within 6 months of colonoscopy.
• To investigate potential differences in tumorigenesis pathways between PCCRCs and detected CRCs.

Main Methods:

• A population-based cross-sectional study of incident CRC cases in Utah (1995-2009).
• Identification and matching of PCCRC cases with detected CRC cases based on age, sex, and hospital site.
• Molecular testing of tumor specimens for microsatellite instability (MSI), CpG island methylation, and KRAS/BRAF mutations.

Main Results:

• PCCRCs were more frequently located in the proximal colon (64% vs. 44%) and diagnosed at an earlier stage (86% vs. 69%) compared to detected CRCs.
• Microsatellite instability (MSI) was significantly higher in PCCRCs (32%) than in detected CRCs (13%).
• MSI was independently associated with PCCRCs (OR, 4.20). No significant difference in 5-year survival was observed between the two groups.

Conclusions:

• PCCRCs exhibit distinct characteristics, including a predilection for the proximal colon and a higher prevalence of MSI, suggesting different tumorigenesis processes compared to detected CRCs.
• Further research is warranted to elucidate the specific genetic pathways involved in the development of post-colonoscopy colorectal cancers.